Jump to content
Ipamorelin Safe

A forward-looking research digest on ipamorelin, the first selective growth hormone secretagogue.

THE SAFETY QUESTION

What is known about Ipamorelin and your safety?

Higher growth hormone doesn't show that your health gets better. The findings in animals are clear, but studies haven't settled benefits or lasting risks for you.

Aurora-green ribbon of light over a deep blue-violet field with a faint peptide-chain lattice

What is ipamorelin, in a few words?

Ipamorelin is a peptide, a chain made from protein building blocks in a lab. Here you'll read what tests found and which risks remain unknown. Your body doesn't make ipamorelin, and no use has drug approval. The trial after bowel surgery didn't show that patients recovered better [3].

Growth hormone helps bones and other tissue grow and mend. A gland under the brain stores growth hormone; doctors call that gland the pituitary. Ipamorelin makes the gland release some of that stored growth hormone. In 1998, animal tests found much less change in other hormones [1].

Cortisol helps your body cope with stress; prolactin is involved in breast milk production. Little change in those hormones doesn't rule out harm elsewhere in you. Studies haven't followed people long enough to settle the risks of lasting use. For reported problems and unanswered risks, read the effects page.

How strongly did ipamorelin affect the animals?

Rats, pigs, and rat cells in dishes released growth hormone strongly after ipamorelin [1]. Ipamorelin worked about as strongly as an older growth-hormone peptide. Researchers also compared ipamorelin with the body's natural hormone that releases growth hormone. Cortisol stayed at or below the level seen with that natural hormone.

The animals received over 200-fold more ipamorelin than needed to raise growth hormone. That means far more of the substance was given to the animals. It doesn't mean their growth-hormone levels rose by that much. Cortisol still didn't rise more than in the natural-hormone comparison.

Ipamorelin and CJC-1295 act on different sites on the growth gland. A review found that these different ways can increase hormone release together [11]. That explains why researchers are interested in combining the two substances. Your health could still fail to improve despite a larger hormone rise.

Over 15 days, adult rats' daily bone growth rose from 42 to 52 micrometres with ipamorelin [4]. A micrometre is a small fraction of a millimetre, used to measure tiny growth. The blood protein that helps tissue grow didn't rise by a measurable amount. Brief growth-hormone rises may explain the bone growth, but your bones weren't tested.

Did the human studies show a health benefit?

In volunteers, ipamorelin caused a short rise in blood growth hormone. Growth hormone reached its highest reading about 40 minutes after treatment [2]. Roughly half the ipamorelin in blood cleared during each two-hour span. Those tests showed how the body handled ipamorelin, rather than improved health.

The Phase 2 trial was an early check of benefit and short-term safety. Researchers included 114 adults recovering from bowel surgery in that test. Researchers timed how long patients waited before eating a meal without trouble [3]. The trial compared ipamorelin with placebo, treatment that contained none of the drug.

Half the ipamorelin patients ate without trouble by 25.3 hours; half waited longer. With placebo, half managed a meal by 32.6 hours, and half waited longer. Chance could explain that difference, so the trial didn't show a benefit. No particular safety problem stood out, but patients were watched only briefly.

No Phase 3 trial, the larger later test before approval, has been completed. The Ipamorelin research page gives you the human findings in more detail. The Ipamorelin effects page includes reports from people taking the substance outside treatment trials. Those accounts haven't been tested fairly, so they can't show benefits for you.

Why does the name still ask about safety?

The word safe in the name doesn't promise that ipamorelin is safe. No drug regulator has approved ipamorelin for treating any health problem. FDA discussed pharmacy use in 2024, including at an October advisory meeting. Those discussions weren't approval to give the substance to patients.

Ipamorelin acetate is ipamorelin joined to acetate, a chemical made from the acid in vinegar. The name describes a chemical form, rather than ordinary table salt. That form's request for the list used by one-patient pharmacies was withdrawn, yet FDA still names it on a safety-concern list for large mixing companies. Leaving that list didn't make ipamorelin an approved ingredient for pharmacy-made medicines.

Ipamorelin is banned both during sport competitions and outside them by the World Anti-Doping Agency. Less change in animal cortisol and prolactin was a useful finding [1]. A different substance acting like ipamorelin damaged rats' hearts, adding concern [6]. Neither finding can tell you whether lasting ipamorelin use would be safe.

You still lack the human studies needed to answer that safety question. No clinic operates here; the publisher explains studies and sells nothing. The study amounts describe experiments, rather than a treatment amount for you. You can find the papers supporting these claims in the Ipamorelin references.